MONDAY, July 26, 2021 (HealthDay News) — Young soccer players have more head impacts during practices but experience more severe head impacts during games, a small, preliminary study shows. The findings could help devise ways to improve head impact safety in youth soccer, according to the researchers. “Headers are aContinue Reading

MONDAY, July 26, 2021 (HealthDay News) — Accidental exposure to fentanyl pain patches is putting children’s lives at risk, the U.S. Food and Drug Administration warns. Fentanyl is a powerful opioid pain reliever; so powerful that fentanyl patches are typically only prescribed to patients who require round-the-clock, long-term pain relief,Continue Reading

FRIDAY, July 23, 2021 (HealthDay News) — Money may not buy happiness but new research suggests it may at least help Americans live longer. “Our results suggest that building wealth is important for health at the individual level, even after accounting for where one starts out in life,” said GregContinue Reading

FRIDAY, July 23, 2021 (HealthDay News) — The controversial new Alzheimer’s drug Aduhelm is creating something of a civil war in medicine, as health networks, hospitals, insurers and individual doctors weigh impending discussions with patients about whether they should take the medication. Many doctors believe the U.S. Food and DrugContinue Reading

Here’s some of HealthDay’s top stories for Friday, July 23: Arguing for & against approval of controversial Alzheimer’s drug. The FDA earlier this month gave its OK to the first new Alzheimer’s drug in years — despite its own panel voting 10-1 against approval. Now, some doctors and hospitals areContinue Reading

FRIDAY, July 23, 2021 (HealthDay News) — A drug that eases hallucinations in people with Parkinson’s disease may be able to do the same for those with dementia, a new clinical trial finds. The medication, called Nuplazid (pimavanserin), is already approved in the United States for treating hallucinations and delusionsContinue Reading